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Abstract
Background: It has been suggested that the proliferative capacity of cells from individuals with HIV or both HIV
and helminth infections is attenuated and cytokine production is dysregulated. This study describes peripheral
blood mononuclear cell proliferation capacity and cytokine profile from individuals with HIV or both HIV and
helminth infections in South Africa.
Methods: Forty HIV-infected and 22 HIV-uninfected participants were randomly selected and stratified into different
helminth infection phenotypes by egg excretion and Ascaris lumbricoides specific –immunoglobulin-E (IgE) levels.
Five day cell cultures of participants, unstimulated or stimulated with Phytohaemaglutinnin, Streptokinase, HIV-1
p24 and Ascaris lumbricoides worm antigens were stained with monoclonal antibody-fluorochrome conjugates
(Ki67-FITC and CTLA-APC-4). Percentage expression of Ki67 and CTLA-4 was measured to determine cell proliferation
and regulation, respectively. Culture supernatants were analysed for the expression of 13 cytokines using the Bioplex
(BioRad) system. Kruskal Wallis was used to test for differences in variables between helminth infected subgroups
who were either having eggs in stool and high IgE (egg+IgEhi); or eggs in stool and low IgE (egg+IgElo); or no eggs
in stool and high IgE (egg−IgEhi) and those without helminth infection (egg−IgElo).
Results: Individuals excreting eggs in stool with high serum IgE (egg+IgEhi phenotype) had potent mitogen
responses but consistently produced low, but statistically non-significant antigen–specific (HIV−1 p24 (p = 0.41) and
Ascaris (p = 0.19) and recall antigen (Streptokinase; p = 0.31) Ki67 responses. The group also had reduced type 1
cytokines. Individuals excreting eggs in stool with low serum IgE( egg+IgElo phenotype) had a more favourable
antiviral profile, characterized by higher IFNγ, IL-2, lower IL-4 and higher IL-10 production.
Conclusion: The findings suggest that dual HIV/helminth infection with egg excretion and/or high Ascaris IgE
phenotye may be linked with poor proliferative capacity and deleterious cytokine profile with regards to HIV control.
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Background
Helminths are among the most common parasitic infec-
tions affecting populations in developing countries, and
have been associated with faster progression of HIV disease
especially in sub-Saharan Africa [1,2] Predominance of type
2- and/or reduced type 1-, increased pro-inflammatory
cytokines, altered distribution of immune cells, increased
HIV receptor molecules (CCR5, CXC-R4 and CD4),
eosinophilia, induction of persistent immune activation
and anergy are some of the immune modulatory factors
by which helminths are suggested to promote HIV infec-
tion and disease progression [1,3]. Both HIV and helminth
infection are characterized by chronic immune activation
and dysregulation of immune responses to pathogens typi-
fied by impaired capacity of immune cells to proliferate in
response to antigenic stimulus [1,4]. Furthermore, it has
been proposed that the predominance of type 2 cytokines
induced by helmiths downregulates type 1 responses [1,5]
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which are critical for the control of HIV infection. In
addition, although still inconclusive to date, HIV disease
progression has long been associated with increased
type 2 or reduction of type 1 cytokines [6]. It is there-
fore expected that dual infection would have an additive
effect on the immune defects associated with the
individual infections. It is noted, however that despite
attempts to derive scientifically conclusive evidence of a
positive impact of deworming on HIV progression,
studies have, in the main, reported conflicting results
[7]. The current study focuses on immunological im-
pact of co-infection, without looking at the effect of
deworming. The aim is to further define immuno-
logical effects associated with helminth infection in the
context of HIV progression parameters in order to
extend this body of knowledge.
The human Ki-67 protein, up-regulated during active
cell cycle phases, has been shown to be a reliable and
specific quantitative marker of cell proliferation [8] or
indicator of cell turnover during chronic infections
such as HIV [9]. The protein is expressed by proli-
ferating cells at G1, S and M phases of the cell cycle
[10]. On the other hand, the down-regulatory mol-
ecule, cytotoxic T lymphocyte associated antigen 4
(CTLA-4) inhibits cell cycle progression through
reduction of cyclin-dependant kinases [11] to maintain
T cell homeostasis.
In South Africa (SA), a large proportion of the popula-
tion is exposed to both HIV and helminth infections
particularly among those living under conditions of pov-
erty [12]. However, there is limited research undertaken
to evaluate the immunological effects of dual infection
in these settings. It is important to investigate the dele-
terious effects of co-infection with HIV and helminths in
the country, where the latter are largely neglected, and
HIV is at pandemic proportions. Such research may
strengthen advocacy for regular mass deworming in line
with the World Health Assembly 54.19 recommendation
of 2001 [13], and as part of a holistic approach to HIV
control and prevention [2,13].
Previously we reported that different helminth in-
fection phenotypes display heterogeneity of immune re-
sponses during HIV and helminth co-infection. Irregular
distribution of immune cells and highly activated
immune profiles were described in a specific group of
individuals with dual infection [14]. The present study
further describes peripheral blood mononuclear cell
proliferation capacity as measured by Ki67 expression,
as well as cytokine profiles in the same HIV-infected
and negative South African adults with different
helminth infection phenotypes in order to determine if
cells from dually infected individuals have skewed
cytokine production and more impaired capacity to
proliferate in response to antigen stimulation.
Methods
Study participants
The current analysis is part of a bigger study that was
approved by the SA Medical Research Council and
Stellenbosch University Ethics Committees (N04/02/
045) in 2002 and 2004 respectively. Written informed
consent was obtained from all participants. The recruit-
ment of participants has been described in detail
elsewhere [12,14]. Essentially participants were recruited
from a low resource informal settlement of Khayelitsha
in the Western Cape province of SA from May 2002 to
November 2003 as part of a cohort study to assess the
effects of regular deworming of HIV-helminth co-
infected individuals. The selected HIV-infected patients
were attending an HIV-support group at the Mathew
Goniwe Clinic, where they received clinical care and the
HIV-uninfected were recruited from individuals accom-
panying patients to the Clinic. Due to budgetary con-
straints for the current analyses, of the 124 HIV+ eligible
participants previously described [14], forty participants
(ten in each of the four subgroups described below) were
systematically randomized for selection and all the
twenty-two HIV-uninfected, eligible individuals were
included by default. At the time of study recruitment,
antiretroviral treatment (ART) was not available at pub-
lic health institutions in South Africa. Hence, the HIV-1
positive participants were antiretroviaral therapy-naïve.
In addition, the unavailability of ART made it difficult to
recruit HIV-uninfected individuals. Participants with
other infectious and systemic immune suppressive
diseases, those on Bactrim prophylaxis and vitamin sup-
plementations, had been pregnant in the previous six
months before study commencement, were using illicit
drugs or excessive alcohol were excluded. Only partici-
pants eighteen years and above, infested with Ascaris
lumbricoides and/or Trichuris trichiura were included.
Helminth infection detection and classification of
phenotypes
Stool samples, collected on two consecutive days were
screened for intestinal parasites eggs by two independent
microscopists using the formol-ether concentration [15]
and the Kato Katz [16] methods respectively. If eggs
were detected with one method and not detectable in
the other, repeat samples were requested to confirm
such discordant results. Participants were telephoned to
return to the clinic and asked to submit two other sets
of stools. Only individuals infected with Ascaris lumbri-
coides and Trichuris trichiuria were included in the
study (and those infected with other helminth and
protozoan parasites excluded from all analyses). Clotted
blood was donated for serum Ascaris -specific IgE. The
HIV-infected and negative groups were stratified into
helminth infection subgroups according to the presence
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or absence of A. lumbricoides and/or T. trichiura eggs in
stool and low or high Ascaris specific IgE. The four dis-
tinct subgroups identified comprised of three helminth –
infected phenotypes: Trichuris and/or Ascaris egg positive
stool and elevated Ascaris IgE (egg+IgEhi), a typical
helminth infection; Trichuris and/or Ascaris egg positive
stool without elevated Ascaris IgE (egg+IgElo), modified T
helper 2 response phenotype; Trichuris and/or Ascaris egg
negative stool but elevated Ascaris IgE (egg−IgEhi) associ-
ated with a balanced Th1/Th2 Th3 response that is associ-
ated with resistance to helminth infection [17]; and those
without evidence of helminth infection, Trichuris and
Ascaris egg negative stool with low Ascaris IgE (egg−IgElo).
All individuals found to be infested by parasites were
given appropriate deworming treatment (if different
from the mebendazole that was given to all participants
as part of the main study).
Stimulation of peripheral blood mononuclear cells
(PBMCs) cultures
Whole blood collected in cell preparation tubes with
Sodium Heparin was separated by standard gradient
centrifugation and cryopreserved in 10% v/v dimethyl-
sulfoxide in RPMI 1640 (Sigma) until the experiments
were done. PBMCs were retrieved by standard methods
and suspended at 1×106 cells/ml in RPMI (Sigma)
supplemented with 2 mM glutamax (Sigma), anti-CD28
and antiCD49d (Becton-Dickenson (BD), 1 μg/ml each;
10% human male AB inactivated serum (Gibco); 2-
mecarptoethanol (βME) 50 μM; penicillin 1000 U/ml and
Streptomycin 100 μg/ml (Gibco). Viability was assessed by
phase contrast microscopy and only cells with >90%
viability used for these experiments. Total volumes of 1 ml
cultures (in U bottom, 48-well polypropylene tissue
culture plates, Costar) were set up in duplicates with:
medium only (unstimulated); Phytohaemagluttinin (PHA)
(Sigma Aldrich) 5 μg/ml; Streptokinase (Aventis) 2 μg/ml;
HIV-1 p-24 ( R & D Inc.,USA) 5 μg/ml; A. lumbricoides
crude worm antigen 10 μg/ml. The cultures were incu-
bated at 37°C, in a humidified 5% CO2 incubator for
5 days. The Ascaris-lumbricoides crude worm antigen was
prepared from female whole worms that were washed,
homogenized, centrifuged for 60 mins at 4°C and serially
filtered through 8 μm, 0.4 μm and 0.2 μm filters. These
were aliquoted and stored at minus 80°C until use.
Anti-Ki67 and anti-Cytotoxic T lymphocyte antigen 4
(CTLA-4) staining and flow cytometry
The capacity of PBMCs to proliferate in response to mito-
gen, cognate and recall antigens was determined by per-
centage expression of the nucleoproliferation antigen- Ki67.
To differentiate between proliferating and activated
cells arrested at the G1 cycle phase [18], the down
regulatory (CTLA-4) was simultaneously determined.
After culture the cells were re-suspended at 1×106 cells/ml.
The cells were stained with 20 μL anti-CTLA-4 mono-
clonal antibody (clone BN13) conjugated to Allophyco-
cyanin (APC) (BD Pharmingen™) and subsequently fixed
and permeabilised in 80% cold ethanol added dropwise,
followed by intracellular staining with 20 μL of anti-Ki67
(clone B56) monoclonal antibodies directly conjugated to
Fluorescein Isothiocyanate (FITC) (BD Pharmingen™) using
the BD Biosciences Pharmingen™ Catalog staining protocol
556003 Rev.8 [19]. The method was modified by staining in
96 well microtiter plates and incubating the stained cells on
ice in the dark for 45 minutes. The following isotype
controls were included: IgG1k FITC and IgG2a APC. The
samples were then analysed on a FACS Calibur flow
cytometer (BD). A minimum of 10 000 events were
acquired manually for each sample tube in list mode
using the Cellquest software and gating in the lympho-
cyte region. For each individual, the unstimulated cells
were used to set the gated region for all subsequent
antigen- specific cells. The samples were analysed using
sample ID numbers that were unlinked to the groups
(subgroups) therefore the researcher was blinded during
acquisition and analysis.
Cytokine production assays in PBMCs of HIV-infected
subgroups
Cytokine analyses were undertaken on HIV-infected sub-
groups only. Cell culture supernatants that had been
harvested after five days’ culture were retrieved from −70°C
freezers and allowed to cool to room temperature before
assays were set up. The Human cytokine LINCOplex KIT
(13-plex) assay was used as per the manufacturer’s instruc-
tions to detect a range of thirteen cytokines. Briefly, plates
were BSA- blocked and washed. Cytokine standards,
controls and unknown samples were added (50 μL total
volumes) to 96 well plates in duplicates and incubated with
antibody-immobilised micro beads. After washing, biotinyl-
ated detection antibodies were incubated with the bound
cytokines. Fluorescent (Phycoerythrin- labeled) streptavidin
was added. A final wash was followed by resuspension in
sheath fluid for analysis in the Bioplex array reader (Bio-Rad)
using the Bioplex Manager 4.1 software. Fifty beads per
region were collected. A seven-point standard curve (0, 3.2,
16, 80, 400, 2000 and 10 000 pg/ml) was constructed using a
5 parameter logistic (5PL) regression and the concentration
of each cytokine calculated against this curve. Unstimulated
cell assays presumably approximated the relative ex-vivo
baseline cytokine profiles therefore a separate analysis
(of unstimulated cytokine results) was made before
calculating the net antigen responses. For the antigen-
specific responses, the baseline (unstimulated) values were
subtracted to give the final concentration in mitogen, PHA,
HIV-p24- and Ascaris worm-challenged cells.
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Statistical analysis
Statistical analysis was conducted in STATA version 10.0
(Stata Corporation, College Station, Texas, USA). Kruskal
Wallis was used to test for differences in the medians and
for multiple comparisons of all measured variables
between the subgroups in HIV-infected and HIV-
uninfected groups. A p-value ≤ 0.05 was considered to be
statistically significant.
Results
Immune and virologic profile of HIV-infected and
HIV-uninfected subgroups
Table 1 presents descriptive statistics of study participants.
The study participants were all females. The HIV-infected
were generally younger than the HIV-uninfected (median
age = 28 and 41 years, respectively). The immune profiles
of the HIV-infected and HIV-uninfected are described in
Table 2. Compared to the HIV-uninfected subgroups
(even though the numbers were much smaller in the
latter), the median percentage expression of HLA-DR in
CD3+ cells were more than double in the HIV-infected
subgroups, while CD38 expression in CD8+ cells was
more than 80% in the latter compared to that in HIV-
uninfected subgroups which ranged between 27% -55%.
Median CD4+ cell counts were lower among the HIV-
infected groups. It is noted that among the HIV-
uninfected, the HIV−egg+IgEhi subgroup had the lowest
median CD4+ cells though still just above the threshold
for onset of immunodeficiency (0.5 cells/ml), however this
was not statistically significant (p = 0.26). Among the HIV-
infected subgroups, while median CD8 +CD38+ values
were comparable within all the subgroups, and CD3+
HLA-DR+ similar in three of the four subgroups, the HIV+
egg+IgEhi subgroup had the highest levels of both activation
markers, with almost all (97%) CD8+ cells expressing
CD38, while the median viral load in this subgroup was
more than 100 000 copies/ml. The CD4+ cell levels in
this subgroup were similar to the subgroup without evi-
dence of helminth infection (egg−IgElo) and in both
cases were above 0.2 cells/ml and lower than the other
two subgroups.
Ki67 expression in HIV-infected and HIV-uninfected groups
The results for the unstimulated cultures were first ana-
lysed separately to determine baseline percentage of
Ki67 expression. The overall median baseline Ki67 expres-
sion was significantly higher (p = 0.01) in cell cultures of
the HIV-infected group compared to the HIV-uninfected
group. For the net antigen-specific results, the baseline
values were subtracted from those obtained in each
antigen-specific response. The net antigen specific re-
sponses were generally weaker in the HIV-infected group
compared to the HIV-uninfected groups.
Proliferation profile in subgroups of HIV-infected
individuals
Among the HIV-infected individuals, the subgroup with
the egg+IgEhi phenotype, expression of Ki67 in unstimu-
lated cells was significantly higher (p = 0.01) than in the
egg−IgElo and the other two subgroups. The median
Ki67 expression by unstimulated cells was up to four to
eight times higher in this subgroup compared to the
egg−IgElo (p <0.01), the egg+IgElo (p = 0.01), and the egg−
IgEhi (p = 0.01) subgroups (Figure 1). In most instances,
the expression of Ki67 was higher in unstimulated than in
antigen-stimulated cells in the egg+IgEhi subgroup such
that the net antigen specific responses had a negative value
or equaled zero.
Table 1 Demographic characteristics of study participants
Variables Phenotype subgroups
Egg+IgEhi (n = 10) Egg+IgElo (n = 10) Egg−IgEhi (n = 10) Egg−IgElo (n = 10)
HIV-infected Median (minimum-maximum)
Age in years 28.2 (19.5–39.6) 34.1 (24.4–49.8) 27.15 (16.4–42.5) 27.7 (19.6–45.5)
Viral load (copies/ml) 101006.5 (7563–1013265) 77290 (1818–307768) 42274.5 (170–222371) 4234 (509–262962)
Ascaris epg 51.5 (0–3786) 479 (2–6799) NA NA
Trichuris epg 82 (0–265) 6.5 (0–234) NA NA
Ascaris IgE 2.375 (0.64–12.1) 0.175 (0.175–0.175) 1.23 (0.65–67.9) 0.175 (0.175–0.175)
Total IgE 823.5 (4.8–4421) 16.3 (5.2–199) 593 (76.8–1995) 67.1 (3.3–447)
HIV-uninfected Egg+IgEhi (n = 5) Egg+IgElo (n = 7) Egg−IgEhi (n = 3) Egg−IgElo (n = 7)
Age in years 43.7 (28.3–74.5) 47.3 (17.9–56.2) 34.3 (20.2–40) 30.2 (22–54.2)
Ascaris epg 0 (0–2268) 10 (0–287) NA NA
Trichuris epg 104 (0–600) 0 (0–370) NA NA
Ascaris IgE 0.47 (0.36–2.63) 0.175 (0.18–0.3) 1.11 (0.61–4.6) 0.175 (0.18–0.3)
Total IgE 592 (106–1149) 15 (24.7–330) 674 (195–2001) 112 (59.7–874)
NA-the subgroups do not have eggs in stool; Epg-Egg per gram of stool; Total IgE- total serum Immunoglobulin-E; Ascaris IgE- Ascaris lumbricoides-specific IgE.
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The egg+IgEhi subgroup showed a tendency towards
impaired proliferative responses to recall and specific anti-
gens but potent mitogen responses. In the HIV-infected -
helminth co-infected egg+IgEhi subgroup, while mitogen
responses were high there were consistently low antigen–
specific (HIV−1 p24 and Ascaris) and recall antigen
(Streptokinase) Ki67 responses relative to all the other
subgroups. These differences were however not significant
(p = 0.41, p = 0.19 and p = 0.31) for HIV-p24, streptokinase
and Ascaris antigens respectively) (Figure 1).
Table 2 Immune parameters for HIV-infected and negative subgroups
Variables Phenotype subgroups
Egg+IgEhi (n = 10) Egg+IgElo (n = 10) Egg−IgEhi (n = 10) Egg−IgElo (n = 10)
HIV-infected Median (minimum-maximum)
CD3 HLA-DR (%) 62 (45–84) 49 (24–84) 31 (1–66) 41 (15–57)
CD8CD38 (%) 97 (92–100) 92 (81–100) 86 (66–98) 89 (82–98)
CD4 cells/ml 0.268 (0.028–0.645) 0.4 (0.05–0.9) 0.44 (0.16–0.99) 0.222 (0.12–0.3)
Viral load (copies/ml) 101007 (7563–1 013 265) 77 290 (1818–307 768) 42 275 (170–222 371) 4234 (509–262 962)
HIV-uninfected Egg+IgEhi (n = 5) Egg+IgElo (n = 7) Egg−IgEhi (n = 3) Egg−IgElo (n = 7)
CD3 HLA-DR (%) 14 (7–30) 21 (9–22) 9 (8–12) 12 (9–21)
CD8CD38 (%) 50 (41–92) 27 (18–67) 55 (38–57) 51 (17–85)
CD4 cells/ml 0.55 (0.13–0.69) 0.75 (0.43–1.2) 0.8 (0.6–1.2) 0.74 (0.4–0.94)
Egg–Faecal helminth eggs, IgE–Ascaris lumbricoides-specific IgE, IgE hi/lo–high/low IgE in serum.
Figure 1 Kruskal Wallis Box and whisker plots for proliferation antigen Ki67 and CTLA-4 antigen expression on unstimulated and
antigen-stimulated lymphocytes of HIV-infected subgroups. Significant differences between subgroups in each panel were set at p value ≤
0.05. PHA stands for Phytohaemagluttinin-, p24 for HIV-1 p-24 antigen-, Asc for Ascaris worm- and Str for Streptokinase- antigen-stimulated cells, Egg
+IgEhi denotes helminth egg positive and elevated Ascaris lumbricoides IgE subgroup, Egg+IgElo represents egg positive and low A. lumbricoides IgE
subgroup, Egg-IgEhi designates egg negative and high A. lumbricoides IgE subgroup, and Egg-Iglo stands for helminth egg negative and low A.
lumbricoides IgE subgroup.
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There were highly significantly stronger Ki67 responses
to PHA mitogen (p = 0.01) in all subgroups with some evi-
dence of helminth exposure (in the egg+IgEhi, egg+IgElo
and egg−IgEhi subgroups) compared to the egg−IgElo sub-
group (Figure 1). The down regulatory protein, CTLA-4,
was also significantly higher (p = 0.05) in unstimulated
cells in the HIV-infected, egg+IgEhi in relation to the egg+
IgElo subgroup, and lower but not significantly, than the
other two subgroups. CTLA-4 expression in response to
PHA challenge was also statistically significantly higher
(p = 0.01) in both groups with stool eggs (the egg+IgEhi
and egg+IgElo) among HIV-infected groups (Figure 1).
Proliferation profile in subgroups of HIV-uninfected
individuals
In all HIV-uninfected subgroups almost all baseline (un-
stimulated) values were lower than antigen- stimulated ones.
However, contrary to the responses observed in the HIV-
infected participants, the baseline Ki67 expression was
significantly higher (p= 0.03) in unstimulated PBMCs from
the helminth-negative (egg−IgElo) subgroup (Figure 2 Panel A).
Among the HIV-uninfected groups mitogen and antigen
specific proliferative responses were not significantly different
in the egg+IgEhi when compared to the other three subgroups
(Panels B, D and E). However, both egg positive subgroups
(the egg+IgEhi and the egg+ IgElo) had significantly higher
Ki67 proliferation responses to the recall antigen Strepto-
kinase (p <0.01 Panel C) and a trend for increased CTLA-4
(p = 0.06) observed for both groups Panel G. Among HIV-
uninfected subgroups CTLA-4 responses were significantly
high for Ascaris stimulated cells in the egg+IgEhi subgroup
(p= 0.01) (Figure 2 Panel H), while these responses were
similar in PHA-stimulated cells (Panel F). It was also observed
that in both HIV-infected and negative groups, some Ki67
responses to Ascaris antigen challenge were made by the
groups without faecal eggs and low specific IgE (egg−IgElo)
(medians 1.1% and 2.64% in HIV− and HIV+, respectively).
Cytokine responses in PBMCs
A wide range of individual levels of cytokines were ob-
tained, therefore predominant patterns will be analysed
in the following sections. In many instances the net
antigen-specific responses were lower.
Pro-inflammatory cytokines
The pro-inflammatory cytokines IL-6 and IL-8 were very
high in unstimulated cells from all the subgroups. Many
of the individual values fell above the upper limit of the
test range (Table 3). In antigen-specific responses, the
levels of these cytokines dropped by between 0–200 up
to 1000-fold in all the subgroups. Baseline TNFα me-
dians were higher in both subgroups with egg positive
stools (egg+IgE hi and egg+IgElo). In HIV-p24 challenged
cells, both groups with a high IgE profile (egg+IgE hi and
egg−IgEhi ) had higher TNFα medians (Table 4), while in
Ascaris-worm challenged cells, TNFα median was high-
est in the egg+IgEhi subgroup (Table 5). The group with-
out evidence of helminth infection (egg−IgElo) had the
lowest or undetectable levels of all pro-inflammatory
(IL-6, IL8 and TNFα) median values in response to
HIV-p24 (Table 4) and Ascaris-stimulation (Table 5).
Anti-inflammatory cytokines
The baseline anti-inflammatory cytokine- IL-1RA levels
were also very high. Both subgroups with positive stool
eggs (egg+IgEhi and egg+IgElo) had relatively lower me-
dian levels of this cytokine compared to the two without
stool eggs. For the latter subgroups, the median values
fell outside the upper limit (>10 000 pg/ml) (Table 3). In
HIV-p24 and Ascaris stimulated assays, IL-1RA was
lower in both subgroups with a high IgE profile (Tables 4
and 5). The egg+IgElo subgroup had a significantly higher
level (p = 0.03) of IL-1RA in response to HIV-1 p24
challenge.
Type 1 cytokines
Generally, the baseline levels of IL-2 and IFNγ were low
(<2 pg/ml) while those of IP-10 and GMSF were higher
(>10 pg/ml) in all assays. All individuals in the egg+IgEhi
subgroup had undetectable baseline levels of the
lymphoproliferative cytokine, IL-2 and a trend for lower
responses between this subgroup and the egg−IgElo
group (p = 0.07) was observed. Similarly, in the egg+IgEhi
subgroup the antiviral cytokine, interferon gamma
(IFNγ) was undetected in all except only one participant
with 1,14 pg/ml IFNγ. Median IFNγ production by
unstimulated cells differed significantly between this sub-
group and the egg+IgElo (p = 0.02) and the egg−IgEhi (p =
0.04) subgroups and there was a trend for a decrease in
this subgroup when compared to the egg−IgElo subgroup
(p = 0.09) (Table 3). Overall, all type 1 cytokines responses
to HIV-p24 were lowest in the cells of individuals in the
egg+IgEhi subgroup (except GMCSF, which was also low
in the egg−IgElo subgroup). In HIV-1p24 and Ascaris anti-
gen stimulated assays, levels of IFNγ were undetectable in
this egg+IgEhi subgroup (Tables 4 and 5). Baseline IP-10
levels were lower in both subgroups with high IgE. Indi-
viduals in the egg+IgElo subgroup had the highest levels of
all baseline type 1 cytokines (except for GMCSF) (Table 3),
while they produced significant levels (p = 0.05) of IFNγ in
response to HIV-1 p24 challenge (Table 3).
Type 2 and regulatory cytokines
IL-5 and IL-13 cytokine levels were very low (less than
1 pg/ml) or not detectable in unstimulated and HIV-1
p24 stimulated cell assays and in the latter all type 2 cy-
tokines were undetectable except in the egg+IgElo group
with an IL-13 median of 2.25 pg/ml. However, IL-5 and
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IL-13 cytokine responses to Ascaris worm challenge
were detectable in all subgroups with evidence of
helminth infection (eggs or high IgE). Baseline IL-4
levels were higher in both groups with a high IgE profile
and lowest in the egg+IgElo subgroup. In HIV-p24 stimu-
lated cells, all type 2 cytokines were low or undetectable,
while in Ascaris stimulated cells, IL-4 was undetectable
in the egg+IgEhi subgroup. Higher baseline (Table 3) and
HIV-p24 (Table 4) levels of the regulatory cytokine-IL-
10 were associated with low IgE subgroups. The egg+
IgElo subgroup had the lowest cytokine-IL-10.
Discussion
Chronic helminth infections have been associated with
suppressed T cell proliferative responses against parasite
antigens as well as other unrelated antigens [20]. Like-
wise it has been shown that the proliferative capacity of
cells from individuals with HIV or both HIV and
helminth infections is attenuated [1,4]. It has also been
suggested that helminth infections result in increased
proinflammatory cytokines while type 2 cytokines are a
classic feature of these infections [1,3]. Predominance of
type two cytokines results in downregulation of the type
1 response, which is crucial for the control of viral
infections including HIV. The present study aimed to
determine if peripheral blood mononuclear cells from
HIV-infected and negative South African adults with
dual (HIV and helminths) infection have decreased
ability to proliferate in response to antigens and mito-
gens using Ki67 expression as a marker, and whether
cytokine responses are altered in the HIV and helminth
co-infected individuals.
The results showed that individuals with an egg+IgEhi
phenotype had a tendency to increased immune activa-
tion, viraemia, impaired antigen specific responses and
retained potent proliferative responses to mitogen. The
percentage expression of Ki67 in response to HIV-1 p24,
Streptokinase and Ascaris worm antigens were lower
than those of PHA. In this subgroup there were
increased background levels of Ki67 and CTLA-4 in
(See figure on previous page.)
Figure 2 Kruskal Wallis Box and whisker plots for proliferation antigen rowsep="1" Ki67 and CTLA-4 antigen expression on unstimulated
and antigen-stimulated lymphocytes of HIV-uninfected subgroups. Significant differences between subgroups in each panel were set at p value
≤ 0.05. PHA stands for Phytohaemagluttinin-, Asc for Ascaris worm- and Str for Streptokinase- antigen-stimulated cells, Egg+IgEhi denotes helminth egg
positive and elevated Ascaris lumbricoides IgE subgroup, Egg+IgElo represents egg positive and low A. lumbricoides IgE subgroup, Egg-IgEhi designates
egg negative and high A. lumbricoides IgE subgroup, and Egg-Iglo stands for helminth egg negative and low A. lumbricoides IgE subgroup.
Table 3 Cytokine levels in unstimulated PBMCs of HIV-infected subgroups
Cytokine (pg/ml) Phenotype subgroups
Median (minimum-maximum)
Egg+IgEhi (n = 10) Egg+IgElo (n = 10) Egg−IgEhi (n = 10) Eggs−IgElo (n = 9)
Pro-inflammatory
IL-6 10762 (9.2–12044) 9158 (4066–12985) 10253 (192–12547) 12671 (1267–>10000)
IL-8 8666 (605–10845) 8653 (5927–11872) 10723 (6785–11994) 11934 (7936–13130)
TNFα 153 (0.46–469) 200 (19–1012) 68 (23–2759) 81(16–398)
Anti-inflammatory
IL-1RA 5369 (50–>10000) 6058 (2359–>10000) >10000 (426–>10000) >10000 (283–>10000)
Type one (Th1)
IL-2 0 (0–0) 1.4 (0–6.8) 0 (0–5.8) 1.09 (0–5.9)
IFNγ 0 (0–1.1) 2.0 (0–252) 1.2 (0.12–808) 0.4 (0–3.5)
IP-10 41 (4–118) 174 (12–7739) 48 (5–1051) 113 (0–640)
GM-CSF 105 (0–177) 85 (15–476) 47 (18–1997) 54 (8–292)
Type two (Th2)
IL-4 20 (3–21) 10 (3–23) 20 (10–48) 16 (13–18)
IL-5 0.1 (0–0.1) 0.08 (0–2.7) 0.2 (0.1–232) (0.1–0.2)
IL-13 0 (0–11) 0.16 (0–161) 3.71 (0–2943) 0 (0–0)
Regulatory
IL-10 31 (0–280) 116 (29–406) 40 (4–403) 147 (3–801)
Egg–Faecal helminth eggs, IgE–Ascaris lumbricoides-specific IgE, IgE hi/lo–high/low IgE in serum, IL-interleukin, IL–1RA interleukin-1 receptor antagonist; IFNγ–interferon
gamma; IP-10–interferon-inducible protein 10, TNFα–Tumour necrosis factor alpha, GM-CSF–granulocyte-monocyte stimulation factor, RPMIc–omplete RPMI medium.
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Table 4 Cytokine production in response to HIV-1 p24 challenge
Cytokine (pg/ml) Phenotype subgroups
Median (minimum-maximum)
Egg+IgEhi (n = 10) Egg+IgElo (n = 10) Egg−IgEhi (n = 10) Egg−IgElo (n = 9)
Pro-inflammatory
IL-6 46.5 (0–1410) 866 (0–4599) 573 (0–12483) 0 (0–1234)
IL-8 864 (0–5293) 1032 (0–3388) 591 (0–3690) 0 (0–1076)
TNF-alpha 20 (0–250) 7 (0–53) 30 (0–1380) 2.9 (0–217)
Anti-inflammatory
IL-1RA 5.1 (0–218) 22 (0–516) 0 (0–412) 11 (0–318)
Type one (Th1)
IL-2 0 (0–0) 0.40 (0–2.1) 0 (0–3.1) 0 (0–4.6)
IFN-γ 0 (0–0) 11.1 (0–66) 1.9 (0–497) 1.4 (0–63.1)
IP-10 9.3 (0–104) 23.5 (0–101) 40.2 (0–1708) 78.9 (0–875)
GM-CSF 0 (0–96) 13.5 (0–65) 8.5 (0–227) 0 (0–96)
Type two (Th2)
IL-4 0 (0–4.7) 0 (0–4.8) 0 (0–7) 0 (0–2.3)
IL-5 0 (0–0) 0 (0–1.1) 0 (0–1.8) 0 (0–0.1)
IL-13 0 (0–2.2) 2.3 (0–45) 0(0–11.4) 0 (0–2.2)
Regulatory
IL-10 10.2 (0–110) 33.9 (0–95) 8.7 (0–305) 11.2 (0–105)
Egg–Faecal helminth eggs, IgE–Ascaris lumbricoides-specific IgE, IgE hi/lo- high/low IgE in serum; IL–interleukin, IL-1RA–interleukin-1 receptor antagonist; IFNγ interferon
gamma; IP-10 interferon-inducible protein 10, TNFαTumour– necrosis factor alpha, GM-CSF-granulocyte-monocyte stimulation factor, RPMIc–omplete RPMI medium.
Table 5 Cytokine production responses to Ascaris crude antigen stimulation in HIV-infected subgroups
Cytokine (pg/ml) Phenotype subgroups
Median (minimum-maximum)
Egg+IgEhi (n = 10) Egg+IgElo (n = 10) Egg−IgEhi (n = 10) Eggs−IgElo (n = 9)
Pro-inflammatory
IL-6 638 (0–1757) 2087 (0–6514) 632 (0–12878) 318 (0–1919)
IL-8 231 (0–4603) 1250 (0–4112) 31 (0–3620) 0 (0–960)
TNF-alpha 123 (0–219) 61 (0–219) 66 (11–1511) 29 (0–389)
Anti-inflammatory
IL-1RA 44 (0–6564) 823 (224–988) 61 (19–761) 101 (123–999)
Type one (Th1)
IL-2 0.6 (0–4.4) 1.7 (0–5.5) 2.8 (0–8.2) 0.4 (0–165)
IFN-gamma 0 (0–13.8) 1.8 (0–99) 14 (0–600) 0.2 (0–110)
IP-10 0(0–87) 0 (0–4.6) 0 (0–154) 0 (0–119)
GM-CSF 16 (0–218) 33 (0–517) 38 (0–452) 11 (326)
Type two (Th2)
IL-4 0 (0–8.4) 4.4 (0–12.2) 6.6 (0–103) 2.1 (0–26)
IL-5 0.2 (0–3.8) 0.2 (0–23) 4.7 (0–460) 0 (0–96)
IL-13 5.5 (0–28) 18 (2.5–355) 81 (0–2120) 2.4 (0–1903)
Regulatory
IL-10 61 (0–138) 77 (0–303) 52 (0–324) 33 (0–248)
Egg–Faecal helminth eggs, IgE Ascaris lumbricoides-specific IgE, IgE hi/lo–high/low IgE in serum; IL–interleukin, IL-1RA–interleukin-1 receptor antagonist; IFNγ–interferon
gamma; IP-10–interferon-inducible protein 10, TNFα–Tumour necrosis factor alpha, GM-CSF granulocyte–monocyte stimulation factor, RPMIc–omplete RPMI medium.
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unstimulated cell cultures in the majority of individuals.
Simultaneous increase of both Ki67 and CTLA-4 indi-
cates activated cells arrested at the G1 phase and not
necessarily proliferating cells [18]. In this study, the
expression of Ki67 was significantly higher among the
HIV-infected compared to the HIV-uninfected individ-
uals, which is in keeping with increased cell turnover
during chronic infections [9]. Furthermore, both Ki67
and CTLA-4 expression by individuals in the HIV+ egg+
IgEhi subgroup were increased in the absence of stimu-
lating antigen. This strongly suggests immune activation
and corroborates our previous findings wherein all
activation markers were highly increased in this subgroup
[14]. Among the HIV-uninfected, HIV-egg + IgE hi
subgroup had the lowest median CD4. However, as can be
seen in Table 3 one of the patients included in this group
had CD4 count of 0,13 cells/ml. Since the group only
comprises of altogether five individuals this could have a
significant impact on the results. Alternatively, it should be
noted that helminth infections are also documented to
decrease the CD4+ cell population [21].
The findings of lower proliferative responses to spe-
cific antigens and strong mitogen responses in the dually
infected HIV + egg+IgEhi individuals agree with previous
reports that HIV and helminths selectively target and
downregulate specific responses directed at them as well
as other cognate antigens [1,17]. In addition, HIV tat
was shown to block CD26 (a costimulatory molecule)
thereby attenuating effective transduction of the stimu-
lation signals [22]. Likewise, both HIV and helminths
are documented to downregulate expression of another
costimulatory molecule, CD28 [1], thus inducing gene-
ralised and specific anergy to themselves and other
infecting pathogens.
All HIV-1 positive subgroups with some evidence of
helminth exposure (egg+IgEhi, egg+IgElo and egg−IgEhi
subgroups) had higher Ki67 responses to mitogen chal-
lenge when compared to the egg−IgElo group (without
helminth infection), implying that their cells were viable
and retained their capacity to proliferate in response to
non-specific stimulation. However, individuals with the
egg+IgEhi phenotype showed decreased proliferative (Ki67)
responses to HIV-1 p24, streptokinase and Ascaris worm
antigens although these differences were not statistically
significant. This may suggest that antigen specific
responses are compromised in the presence of HIV-
helminth co-infections [1]. We found that this
phenomenon is prominent in individuals who excrete eggs
and respond with a high specific IgE phenotype. While the
Ki67 responses to PHA were high in all helminth-exposed
subgroups, egg excretion (egg+IgEhi and egg+IgElo) was
also accompanied by increased PHA-induced CLTA re-
sponses in the HIV-infected group. In the HIV-uninfected
group, both Ki67 and CTLA-4 were increased in response
to the recall antigen in both egg positive subgroups. This
may suggest that the presence of eggs (indicating current
and ongoing infection) is associated with increased non-
specific and recall activation and inherent regulation.
The results also showed that baseline pro-inflammatory
cytokines IL-6 and IL-8 were increased in all the sub-
groups and there was a marked decrease of these markers
in antigen-stimulated assays. High TNFα levels were asso-
ciated with egg excretion or with high Ascaris-specific IgE
in response to antigen-stimulation. Egg excretion may be
associated with ongoing inflammatory processes [23] and
increased TNFα levels were found in the stool egg excre-
tors in this study. Particularly, the egg+IgEhi subgroup
showed higher levels of TNF in unstimulated, HIV-p24
and Ascaris antigen stimulated cells. TNFα alone facili-
tates HIV transcription via the activation of the nuclear
factor kappa-beta while IL-6 and TNFα act synergistically
to promote HIV replication [3]. In this study, while IL-6
and IL-8 were very high in all the subgroups at baseline,
increased TNFα levels were associated with helminth
infection (either egg positivity at baseline or with high
Ascaris-specific IgE profile in antigen-stimulated assays).
This observation is in support of the proposition that
dual infection with HIV and helminths provides a
favourable milieu for HIV propagation [1,3]. This asser-
tion is supported by our finding that all pro-inflammatory
cytokines were lowest in the subgroup with single HIV-1
infection (egg−IgElo) in response to HIV-1 and Ascaris
worm challenge.
Concurrently, lower anti-inflammatory cytokine (IL-
1RA) levels were observed in egg excreting subgroups.
In HIV-p24 and Ascaris antigen challenged cells, IL-1RA
was lower in high IgE subgroups. These findings suggest
that individuals infected or exposed to helminths have
lowered anti-inflammatory responses. The singly HIV-
infected subgroup (egg−IgElo) had the lowest or undetect-
able levels of all the three proinflammatory cytokines,
demonstrating that dual infection leads to both enhanced
pro-inflammatory and impaired anti-inflammatory re-
actions, particularly in the egg+IgEhi phenotype, supporting
a role of helminths in promoting HIV replication [1,3] .
The type 1 cytokines IFNg, IL-2 were generally low in
this study. Nonetheless, lower type 1 cytokines, more
importantly IFNγ and IL-2 in the egg+IgEhi subgroup
were detected, and can be a contributor to enhanced
HIV disease whose control is largely mediated by these
cytokines. IL-2 is a major lymphoproliferative cytokine
that also drives differentiation of lymphocytes into
armed effector cells while IFNγ, as antiviral cytokine,
plays a critical role in killing of virally-infected cells [24].
Production of these two cytokines was lower, not only in
unstimulated PBMCs but also in cells stimulated with
the HIV-1 p24 antigen. Lower levels of the lymphoprolif-
erative cytokine- IL-2 in the egg+IgE hi subgroup are also
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in keeping with low antigen-specific proliferative cap-
acity in these individuals as discussed above.
Furthermore, the significant reduction of IL-2 and
IFNγ with a trend towards decreased antigen-specific
proliferative responses in the egg+IgEhi subgroup corre-
sponds with the notion that defective IL-2 production is
associated with advancing HIV immunodeficiency [6].
However, the changes in expression of type1/type2 cyto-
kines during HIV –helminth co-infection has been chal-
lenged and inconsistent findings reported recently [25].
In addition, the simultaneous reduction of IL-2 and
IFNγ in this group concurs with the findings by Sousa
et al. [26] that HIV-1 progression is associated with
reduction of the population of CD4+ lymphocytes with
potent proliferative capacity and ability to produce IL-2
and IFNγ. In the same context, the results of the present
study corroborate the findings of a tendency towards re-
duction of CD4+ lymphocyte numbers in the egg+IgEhi
subgroup in our previous paper [14]. In addition, our
results showed that CTLA-4 expression was increased in
the egg+IgEhi subgroup. CTLA-4 inhibits production of
IL-2 among other down-modulatory functions [24]. These
provide an immunological basis that is in line with a nega-
tive interaction between HIV and helminth co-infection
[1,3] particularly in the egg+IgEhi individuals.
While IL-4 responses to antigen stimulation were
spurious, at baseline this type 2 cytokine was higher in
high IgE responder subgroups. High IgE and IL-4 are
classic type 2 anti-helminth responses. IL-10 levels were
lower in these subgroups. These high IgE responder
groups displayed lower type 1 and anti-inflammatory
cytokines as discussed above. This lends further support
to the hypothesis that helminth infection induces a type
2 biased cytokine response that dampens type 1 cytokine
production and impairs anti-HIV immune response
[1,3,27].
Taken together these findings suggest that egg excre-
tion and/or high Ascaris specific IgE associated with
lower anti-inflammatory, higher pro-inflammatory and
IL-4 plus lower type 1 cytokines. This cytokine profile,
which was particularly prominent in the egg+IgEhi
subgroup, accompanied by the reported tendency to
impaired specific and recall antigen responses could be
deleterious to immune responses to HIV.
The egg+IgElo subgroup on the other hand showed a
favourable profile, characterized by higher IFNγ, IL-2,
lower IL-4 and higher IL-10. The egg+IgElo subgroup
had the highest levels of type 1 cytokines (except
GMCSF which was highest in the egg+IgEhi individuals);
the lowest IL-4 at baseline and particularly produced a
strong IFNγ response and significant anti-inflammatory
response to HIV-p24 challenge. This cytokine profile
concurs with previous findings that these individuals
mimic the modified Th2 phenotype [14,28]. This suggests
that some individuals who respond with a low IgE to hel-
minth infections may be better able to control HIV infec-
tion, while those with a high IgE and excrete eggs are
more likely to respond poorly to HIV infection.
The present study had some limitations. The costs of
the laboratory tests did not allow for testing of all avail-
able samples. In addition the unavailability of ART
limited the recruitment of potential HIV-uninfected par-
ticipants, hence, the small numbers in some subgroups.
As a result some of the results could not be validated
through statistical analysis. For ethical reasons, limited
amount of blood could be drawn from the HIV-infected
participants because a proportion of them would be im-
munocompromised already. Consequently, cells had to
be split up for assessment of surface activation markers
and the remainder used for setting up cultures for prolif-
eration and subsequent supernatant cytokine assays.
Furthermore, the study used human AB male serum for
cytokine analyses and not serum-free medium. Never-
theless, human AB male serum has been shown to pre-
serve the proliferation capacity of cells [29], which was
one of the aims of this paper. In addition, serum supple-
mented media has been widely used in recommended
protocols [30]. Another limitation of this study was diffi-
culty to find balance for optimum incubation period for
all the cytokines analysed, against the requirement for
longer incubation to expand antigen-specific cellular
responses [31]. Only two cytokines were investigated
(IFNγ and IL-4) from which an optimum of five days
was found for antigen-specific responses. This culture
period may also have increased activation-induced apop-
tosis, particularly in cells from HIV-infected persons that
are documented to be highly susceptible to programmed
cell death [32]. The sharp drop in proinflammatory
cytokines, in particular could be attributable to this
limitation.
Conclusion
Notwithstanding the limitations in this work, the find-
ings suggest that dual HIV/helminth infection with egg
excretion and/or high Ascaris IgE phenotype may be
linked with poor proliferative capacity and deleterious
cytokine profile with regards to HIV control. This study
suggests that dual infection with helminths and HIV
may induce impaired antigen-specific responses and un-
favourable cytokine profiles in individuals with a high
parasite-specific IgE and egg excretion phenotype. Indi-
viduals who responded with low IgE to helminths are
likely to retain competent immune profile in terms of
HIV responses. It is therefore important that workers
who investigate the intricate relationship between HIV
and helminths are cognizant of other host factors such
as the different helminth-infection response phenotypes
described in our work and by others [17].
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Finally, this study was not designed to look at associations
but rather to explore
differences in the different subgroups given the expres-
sion of various cellular markers from an extensive
laboratory analysis. Secondary analysis of this can in
future be used to explore possible associations and con-
trol for multiple comparisons for bigger sample sizes as
the latter was one of the study limitations. However, this
work adds new knowledge, particularly in the South
African context, to the still controversial role of
helminth co-infection on HIV disease.
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